Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2024: USD -328.29 M

Ascendis Pharma A/S Operating Cash Flow is USD -328.29 M for the Trailing 12 Months (TTM) ending December 31, 2024, a -35.02% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2023 was USD -505.24 M, a -3.51% change year over year.
  • Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2022 was USD -523.60 M, a 7.83% change year over year.
  • Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2021 was USD -485.57 M, a 53.98% change year over year.
  • Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2020 was USD -315.36 M, a 61.27% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities